Challenges in the interpretation of dengue vaccine trial results.

Cited by papers we hold 4

• Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms · 2019
  No notice
• Contributions from the silent majority dominate dengue virus transmission · 2018
  No notice
• The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study · 2016
  No notice
• Epidemiological Risk Factors Associated with High Global Frequency of Inapparent Dengue Virus Infections · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.